Suppr超能文献

m6A去甲基化酶在消化系统肿瘤中的作用及机制

Role and mechanisms of m6A demethylases in digestive system tumors.

作者信息

Jiang Lingli, Chen Yang, Luo Qing, Song Guanbin

机构信息

College of Bioengineering, Key Laboratory of Biorheological Science and Technology, Ministry of Education, Chongqing University Chongqing 400030, China.

出版信息

Am J Cancer Res. 2025 Apr 15;15(4):1436-1460. doi: 10.62347/XMAF1290. eCollection 2025.

Abstract

Digestive system tumors are common malignancies in humans, often accompanied by high mortality and poor prognosis. Therefore, intensive research on the pathogenesis of digestive system tumors is imperative. N6-methyladenosine (m6A) is the most common RNA modification in eukaryotes and exerts regulatory effects on RNA expression and metabolism, including splicing, translation, stability, decay, and transport. m6A demethylases belong to the AlkB family of dioxygenases that can catalyze m6A demethylation. Accumulating evidence in recent years has shown that abnormal m6A levels caused by m6A demethylases play crucial roles in different aspects of human cancer development. In this review, we comprehensively summarize the recent findings on the functions and underlying molecular mechanisms of m6A demethylases in cell proliferation, apoptosis, migration, invasion, metastasis, angiogenesis, resistance to chemo- and radiotherapy, and the tumor immune microenvironment (TIME) of digestive system tumors. Furthermore, we discuss the therapeutic potential of targeting these m6A demethylases for treatment.

摘要

消化系统肿瘤是人类常见的恶性肿瘤,常伴有高死亡率和不良预后。因此,深入研究消化系统肿瘤的发病机制势在必行。N6-甲基腺苷(m6A)是真核生物中最常见的RNA修饰,对RNA的表达和代谢发挥调控作用,包括剪接、翻译、稳定性、降解和转运。m6A去甲基化酶属于双加氧酶的AlkB家族,可催化m6A去甲基化。近年来越来越多的证据表明,m6A去甲基化酶导致的m6A水平异常在人类癌症发展的不同方面发挥着关键作用。在本综述中,我们全面总结了m6A去甲基化酶在消化系统肿瘤的细胞增殖、凋亡、迁移、侵袭、转移、血管生成、对化疗和放疗的抗性以及肿瘤免疫微环境(TIME)中的功能及潜在分子机制的最新研究结果。此外,我们还讨论了靶向这些m6A去甲基化酶进行治疗的潜力。

相似文献

1
Role and mechanisms of m6A demethylases in digestive system tumors.
Am J Cancer Res. 2025 Apr 15;15(4):1436-1460. doi: 10.62347/XMAF1290. eCollection 2025.
2
Emerging Roles of N6-Methyladenosine Demethylases and Its Interaction with Environmental Toxicants in Digestive System Cancers.
Cancer Manag Res. 2021 Sep 9;13:7101-7114. doi: 10.2147/CMAR.S328188. eCollection 2021.
3
Recent Advances of m6A Demethylases Inhibitors and Their Biological Functions in Human Diseases.
Int J Mol Sci. 2022 May 22;23(10):5815. doi: 10.3390/ijms23105815.
4
Effects of N6-methyladenosine modification on metabolic reprogramming in digestive tract tumors.
Heliyon. 2024 Jan 11;10(2):e24414. doi: 10.1016/j.heliyon.2024.e24414. eCollection 2024 Jan 30.
5
RNA-Seq data of ALKBH5 and FTO double knockout HEK293T human cells.
Data Brief. 2022 Apr 20;42:108187. doi: 10.1016/j.dib.2022.108187. eCollection 2022 Jun.
6
Distinct RNA demethylation pathways catalyzed by nonheme iron ALKBH5 and FTO enzymes enable regulation of formaldehyde release rates.
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25284-25292. doi: 10.1073/pnas.2007349117. Epub 2020 Sep 28.
7
A study of RNA m6A demethylases in oral epithelial dysplasia and oral squamous cell carcinoma.
J Oral Biol Craniofac Res. 2023 Mar-Apr;13(2):111-116. doi: 10.1016/j.jobcr.2022.12.003. Epub 2022 Dec 10.
8
Research Advances in the Roles of N6-Methyladenosine Modification in Ovarian Cancer.
Cancer Control. 2024 Jan-Dec;31:10732748241256819. doi: 10.1177/10732748241256819.
9
The Significance of N6-Methyladenosine RNA Methylation in Regulating the Hepatitis B Virus Life Cycle.
J Microbiol Biotechnol. 2024 Feb 28;34(2):233-239. doi: 10.4014/jmb.2309.09013. Epub 2023 Oct 31.
10
FTO plays a crucial role in gastrointestinal cancer and may be a target for immunotherapy: an updated review.
Front Oncol. 2023 Oct 12;13:1241357. doi: 10.3389/fonc.2023.1241357. eCollection 2023.

本文引用的文献

1
Burden of Gastrointestinal Tumors in Asian Countries, 1990-2021: An Analysis for the Global Burden of Disease Study 2021.
Clin Epidemiol. 2024 Sep 4;16:587-601. doi: 10.2147/CLEP.S472553. eCollection 2024.
2
Tumour vasculature at single-cell resolution.
Nature. 2024 Aug;632(8024):429-436. doi: 10.1038/s41586-024-07698-1. Epub 2024 Jul 10.
3
Targeting FTO suppresses hepatocellular carcinoma by inhibiting ERBB3 and TUBB4A expression.
Biochem Pharmacol. 2024 Aug;226:116375. doi: 10.1016/j.bcp.2024.116375. Epub 2024 Jun 19.
5
Positive GLI1/INHBA feedback loop drives tumor progression in gastric cancer.
Cancer Sci. 2024 Jul;115(7):2301-2317. doi: 10.1111/cas.16193. Epub 2024 Apr 27.
7
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
8
The antagonistic effect of FTO on METTL14 promotes AKT3 mA demethylation and the progression of esophageal cancer.
J Cancer Res Clin Oncol. 2024 Mar 15;150(3):131. doi: 10.1007/s00432-024-05660-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验